These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8051396)

  • 21. Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma.
    Lin Y; Shi CY; Li B; Soo BH; Mohammed-Ali S; Wee A; Oon CJ; Mack PO; Chan SH
    Ann Acad Med Singap; 1996 Jan; 25(1):22-30. PubMed ID: 8779541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].
    Qin L; Tang Z; Liu K
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):405-8. PubMed ID: 8697987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mutation analysis of the tumor suppressor gene PTEN/MMAC1/TEP1 in human hepatocellular carcinoma].
    Zhang LN; Zha XL; Yu Q; He JY
    Shi Yan Sheng Wu Xue Bao; 2000 Sep; 33(3):223-7. PubMed ID: 12549040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles.
    Andersson M; Jönsson M; Nielsen LL; Vyberg M; Visfeldt J; Storm HH; Wallin H
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):765-70. PubMed ID: 8672994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
    Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
    Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore.
    Shi CY; Phang TW; Lin Y; Wee A; Li B; Lee HP; Ong CN
    Br J Cancer; 1995 Jul; 72(1):146-9. PubMed ID: 7599044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations of the p53 gene in human functional adrenal neoplasms.
    Lin SR; Lee YJ; Tsai JH
    J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Aberrations of tumor suppressor genes in hepatocellular carcinomas].
    Fujimoto Y
    Hokkaido Igaku Zasshi; 1994 Sep; 69(5):1252-60. PubMed ID: 7868063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 gene mutation pattern in rat liver tumors induced by vinyl chloride.
    Barbin A; Froment O; Boivin S; Marion MJ; Belpoggi F; Maltoni C; Montesano R
    Cancer Res; 1997 May; 57(9):1695-8. PubMed ID: 9135010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.
    Shieh YS; Nguyen C; Vocal MV; Chu HW
    Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan.
    Nose H; Imazeki F; Ohto M; Omata M
    Cancer; 1993 Jul; 72(2):355-60. PubMed ID: 8100480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
    Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
    Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
    Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
    Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infrequent mutations of the TP53 gene and no amplification of the MDM2 gene in hepatoblastomas.
    Ohnishi H; Kawamura M; Hanada R; Kaneko Y; Tsunoda Y; Hongo T; Bessho F; Yokomori K; Hayashi Y
    Genes Chromosomes Cancer; 1996 Mar; 15(3):187-90. PubMed ID: 8721685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan.
    Chen FM; Hou MF; Wang JY; Chen TC; Chen DC; Huang SY; Chung YS; Lin SR
    Cancer Lett; 2004 Apr; 207(1):59-67. PubMed ID: 15050734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
    Murakami Y; Hayashi K; Hirohashi S; Sekiya T
    Cancer Res; 1991 Oct; 51(20):5520-5. PubMed ID: 1655254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer.
    Dahiya R; Deng G; Selph C; Carroll P; Presti J
    Biochem Mol Biol Int; 1998 Feb; 44(2):407-15. PubMed ID: 9530523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation.
    Tanaka S; Toh Y; Adachi E; Matsumata T; Mori R; Sugimachi K
    Cancer Res; 1993 Jun; 53(12):2884-7. PubMed ID: 8389246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stepwise participation of p53 gene mutation during dedifferentiation of human thyroid carcinomas.
    Dobashi Y; Sugimura H; Sakamoto A; Mernyei M; Mori M; Oyama T; Machinami R
    Diagn Mol Pathol; 1994 Mar; 3(1):9-14. PubMed ID: 8162258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the p53 gene in European hepatocellular carcinomas and hepatoblastomas.
    Debuire B; Paterlini P; Pontisso P; Basso G; May E
    Oncogene; 1993 Aug; 8(8):2303-6. PubMed ID: 8393166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.